Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | FYN | P06241 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL8976496 | 1.00 | FFAR3 (0.39) | FFAR3LCKFYNALDH1A1TSHR | |
| Hydrogen Peroxide SCHEMBL28118709 | 0.97 | — | — | |
| SCHEMBL37159 | 0.94 | — | — | |
| Silver SCHEMBL11879471 | 0.92 | — | — | |
| SCHEMBL28801073 | 0.92 | — | — | |
| Hydrochloric Acid SCHEMBL28407143 | 0.92 | — | — | |
| SCHEMBL28326608 | 0.92 | — | — | |
| Ethane SCHEMBL1022106 | 0.92 | — | — | |
| SCHEMBL31570186 | 0.92 | — | — | |
| Phosphine SCHEMBL27818086 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113105406-B | Energy-containing molecules of wheel-shaped triazine nitrate and synthetic method thereof | 中国工程物理研究院化工材料研究所 | 2022-10-18 | — | — | CN | claimed |
| CN-113105406-A | Energy-containing molecules of wheel-shaped triazine nitrate and synthetic method thereof | 中国工程物理研究院化工材料研究所 | 2021-07-13 | — | — | CN | claimed |
| US-7250523-B2 | Imido-tethered carbenes of molybdenum for ring-opening metathesis polymerization and ring-closing metathesis | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2007-07-31 | — | — | US | claimed |
| WO-2005086622-A2 | IMIDO-TETHERED CARBENES OF MOLYBDENUM FOR RING-OPENING METATHESIS POLYMERISATION AND RING-CLOSING METATHESIS | MICHIGAN STATE UNIVERSITY (US) | 2005-09-22 | — | — | WO | claimed |
| US-20050101475-A1 | Imido-tethered carbenes of molybdenum for ring-opening metathesis polymerization and ring-closing metathesis | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2005-05-12 | — | — | US | claimed |
| CN-113105406-B | Energy-containing molecules of wheel-shaped triazine nitrate and synthetic method thereof | 中国工程物理研究院化工材料研究所 | 2022-10-18 | — | — | CN | disclosed |
| CN-114573511-A | Continuous synthesis method of metronidazole | 安徽贝克制药股份有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-113105406-A | Energy-containing molecules of wheel-shaped triazine nitrate and synthetic method thereof | 中国工程物理研究院化工材料研究所 | 2021-07-13 | — | — | CN | disclosed |
| CN-112174975-A | Green refining method of isosorbide mononitrate | 鲁南贝特制药有限公司 | 2021-01-05 | — | — | CN | disclosed |
| US-7250523-B2 | Imido-tethered carbenes of molybdenum for ring-opening metathesis polymerization and ring-closing metathesis | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2007-07-31 | — | — | US | disclosed |
| WO-2005086622-A2 | IMIDO-TETHERED CARBENES OF MOLYBDENUM FOR RING-OPENING METATHESIS POLYMERISATION AND RING-CLOSING METATHESIS | MICHIGAN STATE UNIVERSITY (US) | 2005-09-22 | — | — | WO | disclosed |
| US-20050101475-A1 | Imido-tethered carbenes of molybdenum for ring-opening metathesis polymerization and ring-closing metathesis | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2005-05-12 | — | — | US | disclosed |
| US-4542137-A | NONEXPLOSIVE, CARDIOVASCULAR | DR. WILLMAR SCHWABE GMBH & CO. (DE) | 1985-09-17 | — | — | US | disclosed |
| US-4364953-A | CORONARY DISEASE | FIRMA WILLMAR SCHWABE (DE) | 1982-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050101475-A1 | Imido-tethered carbenes of molybdenum for ring-opening metathesis polymerization and ring-closing metathesis | NOXO1, PPOX, CBR1 | FFAR3 2978/4885LCK 1518/4885FYN 2501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.